← feed

Is NCT03177278 results overdue?

Yes — results are overdue. Primary completion was 2017-07-10; the FDAAA-801 reporting deadline (2018-07-10) passed 2903 days ago and no results are posted on ClinicalTrials.gov.

A Study to Assess the Metabolism, Excretion, and Mass Balance of Radio-Labeled Plazomicin

NCT IDNCT03177278 ↗
SponsorAchaogen, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-07-10 (ACTUAL)
Reporting deadline2018-07-10 (completion + 365d)
Days overdue2903
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 0c2383d906d0d2fb… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03177278. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →